News & Alerts
-
Oct- 2023 -31 October
Hengrui Pharma Teams Up with Merck KGaA for Cancer Therapies
Jiangsu Hengrui Pharmaceuticals Co., Ltd (Hengrui Pharma), a globally recognized pharmaceutical company known for its commitment to scientific and technological…
Read More » -
31 October
Next-Generation Sequencing Market Set to Grow by USD 3.41 Billion from 2022 to 2027 at a CAGR of 12.45% – Technavio
According to a recent market study by Technavio, the Next-Generation Sequencing (NGS) market is anticipated to witness significant growth, with…
Read More » -
31 October
EGFR Inhibitors Market to Surge by USD 6.75 Billion by 2028, Led by North America – Report
The global market for Epidermal Growth Factor Receptor (EGFR) inhibitors is projected to witness remarkable growth, surging by USD 6.75…
Read More » -
31 October
Generalized Anxiety Disorder Treatment Market Poised for Positive Growth from 2023 to 2032, Says DelveInsight Report
Generalized Anxiety Disorder Treatment Market is poised for positive growth during the forecast period from 2023 to 2032. This is…
Read More » -
30 October
FDA Cautions Against Buying Specific Eye Drops Due to Infection Concerns
The U.S. Food and Drug Administration (FDA) issued a warning on October 27, 2023, advising consumers not to purchase or…
Read More » -
27 October
Gastroparesis Treatment Market to Reach USD 11.09 Billion by 2030
Infinium Global Research, a leading market research firm, has recently released a comprehensive report on the Gastroparesis Treatment Market. The…
Read More » -
26 October
Fundamental Changes To Medicare’s Part D Drug Benefits for 2024
Image Source Medicare open enrollment is here. It’s time again to review your options and make any necessary changes to…
Read More » -
26 October
West Pharmaceutical Services Boosts 2023 Profit Forecast Amidst Shifting Market Dynamics
West Pharmaceutical Services (WST.N), a leading medical equipment maker, announced on Thursday that it has revised its 2023 adjusted profit…
Read More » -
25 October
Demand for RSV Protection Shot for Babies Outpaces Supply, Prompts CDC Recommendation
In response to soaring demand, the supply of nirsevimab (Beyfortus), a novel vaccine designed to safeguard babies against respiratory syncytial…
Read More » -
25 October
International Flavors & Fragrances (IFF) Explores Potential $3.5 Billion Sale of Pharma Solutions Business
International Flavors & Fragrances (IFF.N) has initiated discussions with an advisor to consider the possibility of selling its pharma solutions…
Read More »